17603,74639,{\rtf1\ansi\ansicpg1252\deff0\deflang1033{\fonttbl{\f0\fnil\fcharset0 Times New Roman;}{\f1\froman\fprq2\fcharset0 Times New Roman;}{\f2\fswiss\fcharset0 Consolas;}{\f3\fnil\fcharset0 Microsoft Sans Serif;}}
{\colortbl ;\red0\green0\blue10;\red0\green0\blue255;\red0\green0\blue0;\red40\green40\blue40;\red255\green255\blue255;}
\viewkind4\uc1\pard\nowidctlpar\hyphpar0\cf1\lang255\kerning1\f0\fs24\par
\pard\nowidctlpar\hyphpar0\sb240\sa160\sl252\slmult1\qc\lang16393\b\fs40 Department of Medical Oncology\lang255\b0\fs24\par
\lang16393\b\fs32 Treatment Summary\lang255\b0\fs24\par
\pard\nowidctlpar\hyphpar0\sa160\sl252\slmult1\qj\lang16393\b\par
\pard\hyphpar0\sa160\sl252\slmult1\qj\cf0\lang9\ul\f1 DIAGNOSIS\ulnone :\line\kerning0\b0 METASTATIC ADENOCARCINOMA PANCREAS (LIVER)- PROGRESSIVE DISEASE\line SOLITORY RESIDUAL LIVER LESION - RFA done on 13/10/18\line S/P: Whipple's hepatojejunostomy  in December 2015\par
\line TYPE \lang16393 2\lang9  DIABETES MELLITUS\line DIABETIC NEPHROPATHY\line SYSTEMIC HYPERTENSION\line\lang16393 DYSLIPIDEMIA\line\lang3081 C\lang16393 ORONARY ARTERY DISEASE-\lang3081  Post PTCA in 2008\lang16393\kerning1\par
\ul\b DRUG ALLERGY\ulnone :\line\lang9\kerning0\b0 Not known\lang16393\kerning1\b\par
\ul CHIEF COMPLAINTS\ulnone :\line\lang9\kerning0\b0 Mr. Paul Varghese, 60-yrs-old male, known Diabetes with nephropathy, hypertension, Coronary artery disease (Post PTCA in 2008), on medications. He was diagnosed to have Carcinoma Pancreas, locally advanced in December 2015 and underwent Whipple's hepatojejunostomy at Appolo, chennai. HPR reported as Adenocarcinoma with nodes negative. CA 19-9 was 60. He received adjuvant chemotherapy for 6 cycles with Gemcitabine, completed in June 2016. He was detected to have stricture at hepaticojejunostomy site in June 2016 and combined percutaneous and endoscopic distal drain placement done and Ballon dilatation and internal drainage, double pigtail placement across hepatojejunostomy site. He  developed metastatic recurrence (Hepatic metastasis) in December 2017. CA 19-9 was 88.6 \lang3081 u/ml\lang9 . He was initiated on palliative chemotherapy with modified FOLFIRINOX regimen. Reassessment CT scan revealed stable disease (\lang3081 Segment VII liver lesion remains status quo, subcapsular liver lesions also remains same size and filling defect seen in Right atria - thrombus. He had given anticoagulation for right atrial thrombus. He received 12 cycles of FOLFIRINOX regimen, completed on 09/07/2018. Reassessment PET CT scan done showed metabolic CR and he was put on follow up. His CA 19-9 was found to be rising and PET CT repeated showed increase in size of solitory hypodense liver lesion measuring 2.9 x 2.8 cms in segment VII with increase in  FDG avidity (SUV max- 4.6, previous SUV 2.5) and no evidence of disease elsewhere. In view of PET avid solitory liver lesion, he underwent RFA on \lang9 13/10/2018. He was on regular follow up. Re assesment PET CT scan done showed \lang3081 abnormal increased FDG uptake noted in the hypodense nodules in segment IVA, IVB and segment VI (SUV 6.3),  peripheral enhancing lesion with central fluid and multiple air pockets in segment VII (RFA cavity, s/o post procedure fluid collection., ? abscess)SUV - 4.7 and subsegmental atelectasis in basal segment of right lung lower lobe. His CA 19-9 is 69 u/ml. Liver abscess aspiration was done on last admission and was treated according to sensitivity. In view of progressive disease it was decided to start him on nextline chemotherapy with Nab Paclitaxel/Gemcitabine. \line Admitted for initiation of next line chemotherapy. \lang16393\kerning1\ul\b\par
EXAMINATION\ulnone :\b0  \line Vitals stable\lang255\par
\lang16393\ul\b PRE CHEMO INVESTIGATIONS\ulnone :\line\b0 Within normal limits\lang3081\kerning0\f2\fs20\line\lang16393\kerning1\b\f1\fs24\line\lang9\ul CHEMOTHERAPY GIVEN\ulnone :\line CYCLE \lang16393 2\lang9  \lang16393 Day 15\lang9  (\lang16393 19\lang9 /0\lang16393 2\lang9 /2019)\line\b0 Inj. EMESET 8 mg slow IV\line Inj. PANTOP 40 mg slow IV \line\line Inj. BEVETEX (NAB PACLITAXEL) 200 mg administer via syringe pump over 30 min\line Inj. \lang16393 GEMCITE\lang9  (GEMCITABINE) 1\lang16393 4\lang9 00 mg in 250 ml NS over 30 min\lang16393  \lang3081\kerning0\par
\pard\hyphpar0\sa200\sl276\slmult1\qj\lang9\kerning1\ul\b DISCHARGE MEDICATIONS\ulnone : \line\b0 Tab EMESET 4 mg 1-0-1 x 2 days\line Tab PANTOCID 40 mg 1-0-0 x 5 days\line Tab GERBISA 10 mg if needed for constipation\line\line\pard\sa200\sl276\slmult1\qj\kerning0 Tab. NEBICARD T 1-0-0 x 2 weeks \line Cap PANLIPASE 25000 units 2-2-2 x  to be contiued\line Tab ULTRACET if needed for pain\line Inj. NOVORAPID FLEXPEN 26u - 26u - 16u to be contiued\line Inj. LANTUS SOLOSTAR 16 units at bedtime to be contiued\line Tab  LOSAR 50mg 1-0-0 to be continued\kerning1\par
\pard\hyphpar0\sa160\sl252\slmult1\qj\ul\b REVIEW ON\ulnone\b0 : \line\lang3081\kerning0 Review for next chemo\lang16393 therapy\lang3081  on 27/02/19 with CBC, CA 19-9,  RFT\lang16393  report\lang3081\par
\lang16393\kerning1\ul\b CONDITION AT THE TIME OF DISCHARGE\ulnone :\line\b0 Stable\b\par
\pard\nowidctlpar\hyphpar0\sa160\sl252\slmult1\qj\cf1\ul\f0 POST CHEMOTHERAPY INSTRUCTIONS\ulnone :\lang255\b0\par
\lang16393\b\par
\pard\nowidctlpar\hyphpar0\sa200\sl276\slmult1\qj\lang9\b0       1. Ask your doctor any doubts regarding disease and treatment.\lang255\par
\lang9       2. There is no specific diet recommended after chemotherapy.\lang255\par
\lang9       3. Check blood counts in between and SMS your doctor (if requested).\lang255\par
\pard\nowidctlpar\hyphpar0\fi-360\li720\sa160\sl252\slmult1\qj\lang9 4. Do blood investigations prior to next cycle of chemotherapy as requested by your doctor.\lang255\par
\lang9 5. Please inform your regular medications to your doctor.\lang255\par
\lang9 6. Bring day care chemotherapy card with you.\lang255\par
\pard\nowidctlpar\hyphpar0\sa200\sl276\slmult1\qj\lang9       7. Avoid over the counter medications/ alternative medicine unless allowed by your doctor.\lang255\par
\lang9       8. If you develop fever more than or equal to \lang16393 100 F or severe vomiting, tiredness, contact the     \tab hospital/ Doctor immediately\lang255\par
\lang16393       9. Please have the discharge summary with you when you call your doctor.\lang255\par
\lang16393       10. Please note down Emergency numbers:\lang255\par
\pard\nowidctlpar\hyphpar0\sa160\sl252\slmult1\qj\lang16393\b\par
\pard\nowidctlpar\hyphpar0\li720\sa160\sl252\slmult1\qj\par
Rajagiri Hospital: \i 0484-2905000\i0\tab\tab\lang255\b0\par
\pard\nowidctlpar\hyphpar0\sa160\sl252\slmult1\qc\lang16393\b\i\fs28\ldblquote Wish you a speedy recovery\rdblquote\lang255\b0\i0\fs24\par
\pard\nowidctlpar\hyphpar0\sa160\sl252\slmult1\lang16393\fs22 Name and Signature of Consultant\lang255\fs24\par
\lang16393\fs22\par
\pard\nowidctlpar\hyphpar0\lang1033\b Dr. Sanju Cyriac, MD (General Medicine), DM (Medical Oncology), DNB\lang255\b0\fs24\par
\lang1033\fs22 Consultant - Medical Oncology\tab\tab\tab\tab\lang255\fs24\line\lang1033\fs22 Rajagiri Hospital\lang255\fs24\par
\lang1033\fs22 Phone no: +91 9747880036\tab\lang255\fs24\line\lang1033\fs22 E-Mail: \cf2\ul sanju.cyriac@rajagirihospital.com\cf1\lang255\ulnone\fs24\par
\lang1033\fs22\par
\b Dr. Subi T. S., MS (General surgery AIIMS, DELHI), MCh (Surgical Oncology, TATA, MUMBAI)\lang255\b0\fs24\par
\lang1033\fs22 Consultant - Surgical Oncology\tab\tab\tab\tab\lang255\fs24\line\lang1033\fs22 Rajagiri Hospital\lang255\fs24\par
\lang1033\fs22 Phone no: +91 8547737149\tab\lang255\fs24\line\lang1033\fs22 E-Mail: \cf2\ul subi.ts@rajagirihospital.com\cf1\lang255\ulnone\fs24\par
\lang1033\ul\fs22\par
\ulnone\b Dr. Varun Rajan MD (Internal Medicine), DM (Medical Oncology)\lang255\b0\fs24\line\lang1033\fs22 Consultant - Medical Oncology\tab\tab\tab\tab\lang255\fs24\line\lang1033\fs22 Rajagiri Hospital\lang255\fs24\par
\lang1033\fs22 E-Mail: \cf2\ul varun.rajan@rajagirihospital.com\cf1\lang255\ulnone\fs24\par
\pard\line\cf0\lang16393\kerning0\b\fs22 Dr. Ayesha Jaleel,DMRT,DNB(Radiation Oncology)\par
\lang1033\b0 Consultant \tab\tab\tab\tab\lang255\fs24\line\lang1033\fs22 Rajagiri Hospital\par
\pard\cbpat5\cf1\lang16393\kerning1\fs24 Phone no: +91 \cf3\kerning0 9645884553\par
\cf1\kerning1\fs22 E-Mail: \cf2\ul ayesha.jaleel@rajagirihospital.com\cf3\kerning0\ulnone\fs24\par
\pard\nowidctlpar\hyphpar0\cf1\lang1033\kerning1\fs22  \lang255\fs24\par
\pard\cf0\lang1033\kerning2\b\fs22 Ms. Anooja  Jose\b0\par
Physician Assistant\par
\pard\nowidctlpar\sa200\sl276\slmult1 Rajagiri Hospital\par
\pard\nowidctlpar\hyphpar0\cf1\kerning1\fs17\par
\par
\pard\cf4\highlight5\kerning0\b\i\fs22 Rajagiri Telemedicine Service\b0  - Video Consult with your doctor,\lang16393  \lang1033 from the comfort of your home, using laptop/Mobile and Internet. To book a tele-consult, e-mail to\lang16393  \ul telemedicine@rajagirihospital.com\cf0\highlight0\lang1033\ulnone\i0\f3\fs17\par
},<Age:61:Age>,<Sex:1:Sex>,2019-02-19 14:12:59.963000000
